ERβ as a mediator of estrogen signaling in inflammatory breast cancer
A new editorial paper titled "ERβ as a mediator of estrogen signaling in inflammatory breast cancer" has been published in Oncotarget.
Jul 3, 2023
0
1
A new editorial paper titled "ERβ as a mediator of estrogen signaling in inflammatory breast cancer" has been published in Oncotarget.
Jul 3, 2023
0
1
An accurate tool that is readily available could be used to predict whether frail patients are likely to survive intensive cancer treatments such as chemotherapy, according to researchers from the University of Surrey.
Jun 26, 2023
0
0
Researchers have found that nanotechnology can increase chemotherapy's effectiveness. The new research could be good news for people who develop peritoneal cancer in the future.
Jun 20, 2023
0
47
Together, the McGill University Health Centre (MUHC), the Centre hospitalier de l'Université de Montréal (CHUM) and St. Mary's Hospital Center (SMHC) have contributed to an international clinical trial that will change ...
Jun 20, 2023
0
43
The American Society for Radiation Oncology (ASTRO) Gastrointestinal Cancers Resource Panel issued the following statement today regarding the PROSPECT clinical trial for patients with rectal cancer:
Jun 7, 2023
0
29
A new research paper was published in Oncotarget, titled "Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC)."
Jun 7, 2023
0
2
Nationwide shortages of two dozen chemotherapy drugs are leading to rationing and delays in treatment for cancer patients, local and national authorities say.
May 22, 2023
0
4
Gastric cancer is the fifth most commonly diagnosed malignancy worldwide. It ranks a sad third in cancer-related causes of death. The reason for this is late diagnosis coupled with rapid spread of tumor cells in the body.
May 8, 2023
0
29
A recent clinical trial showed that the drug combination of cemiplimab plus platinum chemotherapy can prolong survival in patients with advanced lung cancer when compared with placebo plus platinum chemotherapy. Now an analysis ...
May 8, 2023
0
11
An innovative cancer drug discovered by scientists at The Institute of Cancer Research, London, is set to enter a new clinical trial.
May 5, 2023
0
3